Key Companies Covered in the Nasal Drug Delivery Devices Market Research Report are Consort Medical plc., Teva Pharmaceutical Industries Ltd., H&T Presspart Manufacturing Ltd., 3M, GOFIRE INC., Nemera, AptarGroup, Inc., Vectura Group plc and other key market players.

Pune, March 04, 2020 (GLOBE NEWSWIRE) -- The global Nasal Drug Delivery Devices Market size is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Devices Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nasal-drug-delivery-devices-market-100415

What are the Key Objectives of this Report?

The report provides a comprehensive overview of the market for nasal drug delivery systems and its various growth parameters. These include factors driving, challenging, and providing opportunities to the market. Besides this, the report discusses the competitive landscape and lists the names of players operating in the market and the major strategies adopted by them. Adoption of different strategies will help key players to strive for the leading position in the market. It also discusses the key segments in the market based on factors such as type, application, end user, distribution channel, and others. Additionally, the report provides insights into the market, major industry developments, and current Nasal Drug Delivery Devices Market trends. It is available for sale on the company website.

Market Drivers:

Rising Awareness About Nasal Spray and its Benefits Will Help Market Gain Impetus

The increasing prevalence of respiratory disorders among people is a major factor boosting the Nasal Drug Delivery Devices Market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”

On the flipside, lack of awareness about inhalers along with their usage, especially amongst the older population may cause hindrance to the overall market. Nevertheless, the rising awareness about the benefits of DPIs and MDIs is expected to help increase their popularity in the market. This, as a result, will give significant impetus to the market in the long run.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-drug-delivery-devices-market-100415

Regional Analysis 

Europe to Dominate Owing to Rising Prevalence of Asthma

Geographically, the global Nasal Drug Delivery Devices Market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. This dominance is attributable to the increasing prevalence of asthma, coupled with the rise in awareness about nasal sprays and their benefits. Besides this, there is the rising popularity of inhalers in developing nations of this region, thereby boosting the regional market.

Apart from this, Asia Pacific market share is likely to attract significant Nasal Drug Delivery Devices Market share owing to the rise in awareness campaigns about the use of inhalers and its benefits. Moreover, biopharma companies are utilizing novel technologies for introducing MDI and DPI into the regional market for higher revenue generation during the forecast period.

Competitive Landscape –

Demand for Nasal Drug Products to Fuel as Companies Focus on Launching Eco-friendly Inhalers

Manufacturers of the intranasal drug delivery devices are focusing on new product launches to stand out in the market competition and are therefore investing huge sums into research and development for the same. In addition to this, companies are trying to launch environment-friendly inhalers for COPD and asthma patients. They are also promoting advanced technologies by introducing software and advanced services for enhanced user experience. Most of the startup companies in this market are trying to implement applications of agglomerated vesicle technology, particle engineering, nanotechnology, and others for delivering medications to COPD and asthma patients.

List of Key Companies Operating in Nasal Drug Delivery Technology Market include:

• Consort Medical plc. (United Kingdom)
• Teva Pharmaceutical Industries Ltd.
• H&T Presspart Manufacturing Ltd.
• 3M
• GOFIRE INC.
• Nemera
• AptarGroup, Inc. (United States)
• Vectura Group plc (United Kingdom)
• Others

Noteworthy Industry Development of Pulmonary Drug Delivery Devices Market Include:

December 2019 – An environment-friendly MDI inhaler was launched at the United Nations Climate Change Conference by Chiesi for COPD and Asthma patients. An investment plan worth USD 382.76 million was made by the company for five years to launch the new product in the market. The company also aims to reduce the overall carbon footprint of MDI by 90%.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nasal-drug-delivery-devices-market-100415

Detailed Table of Content:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • New Product Launch
  • Pipeline Analysis
  • Technological Advancements in the Nasal Drug Delivery Devices Market
  • Prevalence of Disease Indications
  • Key Industry Developments - Mergers, Acquisitions, and Partnerships
• Global Nasal Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Type
    • Dry Powder Inhalers (DPI)
    • Metered Dose Inhalers (MDIs)
    • Nebulizers
  • Market Analysis, Insights and Forecast – By Application
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Others
  • Market Analysis, Insights and Forecast – By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Market Analysis, Insights and Forecast – By Geography
    • North America
    • Europe
    • Asia pacific
    • Latin America
    • Middle East & Africa

TOC Continued….!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/nasal-drug-delivery-devices-market-100415

Have a Look at Related Reports:

Injectable Drug Delivery Market Size, Share and Global Trend By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others) and Geography Forecast till 2026

Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026

Dermatitis Drugs Market Size, Share and Global Trend Product By Therapy (Chemotherapy, Radiotherapy, Targeted therapy) By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma) By End User(Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers) and Geography Forecast to 2025

Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026

Orphan Drugs Market Size, Share and Industry Analysis By Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Regional Forecast, 2018 – 2025

Diabetes Drugs Market Size, Share and Industry Analysis By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Regional Forecast 2019 – 2026

Hiv/Aids Drugs Market Size, Share and Industry Analysis By Drug Class (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors, Combination HIV Medicines, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Hemophilia Drugs Market Size, Share and Industry Analysis By Disease Indication (Hemophilia A, B & C), By Therapy Type (Recombinant Therapy, Plasma Therapy & Others), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast 2018-2025

Veterinary Drugs Market Size, Share and Industry Analysis by Product (Anti-infectives, Anti-inflammatory, Parasiticides, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral,Topical), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others,) and Regional Forecast, 2018 – 2025

Hepatitis C Drug Market Size, Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/nasal-drug-delivery-devices-market-9633